Sartorius Pref Shs
Price
Price
CHART BY
Historical dividends and forecast
Sartorius Pref Shs has so far distributed $0.802 in 2024. The next dividend will be paid on 04.04.2025
CHART BY
Frequently asked questions
What is Sartorius Pref Shs's market capitalization?
What is Sartorius Pref Shs's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Sartorius Pref Shs?
What are the analyst ratings and target price for Sartorius Pref Shs's stock?
What is Sartorius Pref Shs's revenue over the trailing twelve months?
What is the EBITDA for Sartorius Pref Shs?
What is the free cash flow of Sartorius Pref Shs?
How many employees does Sartorius Pref Shs have, and what sector and industry does it belong to?
What is the free float of Sartorius Pref Shs's shares?
Financials
- Market Cap
- $15.53B
- EPS (TTM)
- $1.263
- Free Float
- 22.87M
- P/E ratio (TTM)
- 178.02
- Revenue (TTM)
- $3.47B
- EBITDA (TTM)
- $909.41M
- Free Cashflow (TTM)
- $292.67M
Pricing
- 1D span
- $219.00$225.80
- 52W span
- $212.42$417.50
Analyst Ratings
The price target is $283.05 and the stock is covered by 23 analysts.
Buy
12
Hold
9
Sell
2
Information
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
- Employees
- 14,614
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- DE0007165631
- Primary Ticker
- SRT3